Quoin Pharmaceuticals Ltd Adr (QNRX)

Jan 14, 2025

Quoin reports progress in pediatric skin disorder study - Investing.com

Jan 14, 2025

Jan 07, 2025

PRISM MarketView Spotlights Quoin Pharmaceuticals CEO Dr. Michael Myers as Specialty Pharma Shares News of Highly Positive Interim Data in Most Advanced, Comprehensive Netherton Syndrome Trials - GlobeNewswire Inc.

Jan 07, 2025

Jan 06, 2025

Quoin Pharmaceuticals reports positive trial results for skin treatment - Investing.com

Jan 06, 2025

Jan 06, 2025

Quoin reports positive results in Netherton Syndrome study - Investing.com

Jan 06, 2025

Dec 28, 2024

Quoin Pharmaceuticals CFO Dunn Gordon buys $54,999 in shares - Investing.com India

Dec 28, 2024

Dec 27, 2024

Quoin Pharmaceuticals CEO Michael Myers acquires $250,000 in shares By Investing.com - Investing.com South Africa

Dec 27, 2024

Dec 27, 2024

Quoin Pharmaceuticals director Anthony Culverwell buys $45,000 in shares - Investing.com India

Dec 27, 2024

Dec 27, 2024

Quoin Pharmaceuticals COO Denise Carter buys $250,000 in shares - Investing.com India

Dec 27, 2024

Dec 27, 2024

Quoin Pharmaceuticals COO Denise Carter buys $250,000 in shares By Investing.com - Investing.com South Africa

Dec 27, 2024

Dec 27, 2024

Quoin Pharmaceuticals director Anthony Culverwell buys $45,000 in shares By Investing.com - Investing.com South Africa

Dec 27, 2024

Dec 27, 2024

Quoin Pharmaceuticals CFO Dunn Gordon buys $54,999 in shares By Investing.com - Investing.com South Africa

Dec 27, 2024

Dec 20, 2024

Quoin Pharmaceuticals sets terms for public offering - Investing.com

Dec 20, 2024

Dec 19, 2024

Quoin Pharmaceuticals advances Netherton Syndrome study - Investing.com India

Dec 19, 2024

Dec 11, 2024

Quoin Pharmaceuticals amends shareholder rights, adjusts executive compensation - Investing.com India

Dec 11, 2024

Nov 07, 2024

Quoin Pharmaceuticals Provides Corporate Update and Announces Third Quarter 2024 Financial Results - Yahoo Finance

Nov 07, 2024

Nov 05, 2024

Quoin Pharmaceuticals advances Netherton syndrome treatment trial - Investing.com

Nov 05, 2024

Oct 31, 2024

Quoin Pharmaceuticals granted extension to meet Nasdaq listing - Investing.com India

Oct 31, 2024

Oct 22, 2024

Quoin Pharmaceuticals expands UK clinical trials for rare disease - Investing.com

Oct 22, 2024

Sep 30, 2024

Quoin Pharmaceuticals sets date for 2024 shareholder meeting - Investing.com

Sep 30, 2024

Sep 12, 2024

Balance Sheet Insights: Quoin Pharmaceuticals Ltd ADR (QNRX)’s Debt-to-Equity and Long-Term Debt/Eq Ratios - The Dwinnex

Sep 12, 2024

Sep 12, 2024

Quoin Pharmaceuticals CFO buys shares worth over $23,000 - Investing.com

Sep 12, 2024

Sep 11, 2024

Healthy Upside Potential: Quoin Pharmaceuticals Ltd ADR (QNRX) - SETE News

Sep 11, 2024

Sep 10, 2024

A closer look at QNRX’s price-to-free cash flow ratio - US Post News

Sep 10, 2024

Sep 05, 2024

Quoin Pharmaceuticals COO acquires $28,737 in company shares - Investing.com

Sep 05, 2024

Sep 05, 2024

Quoin Pharmaceuticals CEO acquires shares worth over $28k - Investing.com

Sep 05, 2024

Aug 23, 2024

Quoin Pharmaceuticals (NASDAQ:QNRX) Stock Quotes, Forecast and News Summary - Benzinga

Aug 23, 2024

Aug 02, 2024

QNRX Stock Hits 52-Week Low at $0.57 Amid Market Challenges - Investing.com Australia

Aug 02, 2024

Mar 27, 2024

symbol__ Stock Quote Price and Forecast - CNN

Mar 27, 2024

Mar 26, 2024

GLMD Stock Quote Price and Forecast - CNN

Mar 26, 2024

Mar 15, 2024

Earnings call: Quoin Pharmaceuticals reports Q4 progress and outlook By Investing.com - Investing.com South Africa

Mar 15, 2024

Aug 05, 2022

Major Indexes Muted Following Strong Jobs Report - Schaeffers Research

Aug 05, 2022

Jul 27, 2011

ADVFNFree stock and cryptocurrency prices, charts, market news and streaming real-time quotes. - ADVFN

Jul 27, 2011